246 related articles for article (PubMed ID: 19154480)
21. [Evaluating the treatment satisfaction of vardenafil in men with erectile dysfunction and female partners by the Treatment Satisfaction Scale].
Deng CH; Sun XZ
Zhonghua Nan Ke Xue; 2005 Sep; 11(9):716-9. PubMed ID: 16209218
[TBL] [Abstract][Full Text] [Related]
22. Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners.
Ralph D; Eardley I; Kell P; Dean J; Hackett G; Collins O; Edwards D
BJU Int; 2007 Jul; 100(1):130-6. PubMed ID: 17488308
[TBL] [Abstract][Full Text] [Related]
23. Treatment of erectile dysfunction.
Dinsmore W
Int J STD AIDS; 2004 Apr; 15(4):215-21. PubMed ID: 15075013
[TBL] [Abstract][Full Text] [Related]
24. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
Mulhall JP; McLaughlin TP; Harnett JP; Scott B; Burhani S; Russell D
J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology of phosphodiesterase 5 inhibitors.
Carrier S
Can J Urol; 2003 Feb; 10 Suppl 1():12-6. PubMed ID: 12625845
[TBL] [Abstract][Full Text] [Related]
26. Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).
Montorsi F; Padma-Nathan H; Glina S
Urology; 2006 Sep; 68(3 Suppl):26-37. PubMed ID: 17011373
[TBL] [Abstract][Full Text] [Related]
27. Sildenafil or vardenafil nonresponders' erectile response to tadalafil.
Ozgur BC; Gonenc F; Yazicioglu AH
Urol J; 2009; 6(4):267-71. PubMed ID: 20027555
[TBL] [Abstract][Full Text] [Related]
28. The utility of sildenafil citrate for infertile men with sexual dysfunction: a pilot study.
Boorjian S; Hopps CV; Ghaly SW; Parker M; Mulhall JP
BJU Int; 2007 Sep; 100(3):603-6. PubMed ID: 17590181
[TBL] [Abstract][Full Text] [Related]
29. Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury.
Giuliano F; Rubio-Aurioles E; Kennelly M; Montorsi F; Kim ED; Finkbeiner AE; Pommerville PJ; Colopy MW; Wachs BH;
Spine (Phila Pa 1976); 2008 Apr; 33(7):709-15. PubMed ID: 18379396
[TBL] [Abstract][Full Text] [Related]
30. [Tadalafil and patients preference in the treatment of erectile dysfunction].
Hu JL; Chen B
Zhonghua Nan Ke Xue; 2006 Dec; 12(12):1145-8. PubMed ID: 17201266
[TBL] [Abstract][Full Text] [Related]
31. Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis.
Valiquette L; Montorsi F; Hellstrom WJ; Giuliano F; Homering M; Taylor T; Eardley I;
Can J Urol; 2005 Jun; 12(3):2687-98; discussion 2699. PubMed ID: 16011816
[TBL] [Abstract][Full Text] [Related]
32. A 6 month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erectile dysfunction.
Rubio-Aurioles E; Reyes LA; Borregales L; Cairoli C; Sorsaburu S
Curr Med Res Opin; 2013 Jun; 29(6):695-706. PubMed ID: 23540375
[TBL] [Abstract][Full Text] [Related]
33. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
Gresser U; Gleiter CH
Eur J Med Res; 2002 Oct; 7(10):435-46. PubMed ID: 12435622
[TBL] [Abstract][Full Text] [Related]
34. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors.
Taylor J; Baldo OB; Storey A; Cartledge J; Eardley I
BJU Int; 2009 May; 103(10):1392-5. PubMed ID: 19154494
[TBL] [Abstract][Full Text] [Related]
35. A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction.
El-Meliegy A; Rabah D; Al-Mitwalli K; Mostafa T; Hussein T; Istarabadi M; Lei Y; Gurbuz S
Curr Med Res Opin; 2013 Jun; 29(6):707-17. PubMed ID: 23540436
[TBL] [Abstract][Full Text] [Related]
36. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.
Vickers MA; Satyanarayana R
Int J Impot Res; 2002 Dec; 14(6):466-71. PubMed ID: 12494279
[TBL] [Abstract][Full Text] [Related]
37. Co-possession of phosphodiesterase type-5 inhibitors (PDE5-I) with nitrates.
Chang LL; Ma M; Allmen Hv; Henderson SC; Harper K; Hornbuckle K
Curr Med Res Opin; 2010 Jun; 26(6):1451-9. PubMed ID: 20394470
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of erectile dysfunction after radical retropubic prostatectomy with PDE5 inhibitor].
Jin W; Huang YR
Zhonghua Nan Ke Xue; 2005 Sep; 11(9):708-12. PubMed ID: 16209216
[TBL] [Abstract][Full Text] [Related]
39. [From better erection to better sex: viagra updates 2005].
Zhang K
Zhonghua Nan Ke Xue; 2005 Oct; 11(10):796-9. PubMed ID: 16281519
[TBL] [Abstract][Full Text] [Related]
40. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
Ahn TY; Lee SW; Kim SW; Yang DY; Park NC; Min KS; Park K; Paick JS; Dyachkova Y; Dwight T; Lee MS
Asian J Androl; 2007 Nov; 9(6):760-70. PubMed ID: 17968461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]